Total Payments
$635.59
2024 Payments
$49.88
Companies
16
Transactions
26
Medicare Patients
6,702
Medicare Billing
$292,282
Payment Breakdown by Category
Food & Beverage$635.59 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $635.59 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $107.28 | 1 | $0 (2023) |
| TerSera Therapeutics LLC | $102.28 | 2 | $0 (2018) |
| Roche Diagnostics Corporation | $80.82 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $49.88 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.74 | 3 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $36.85 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $35.42 | 2 | $0 (2020) |
| Ipsen Biopharmaceuticals, Inc | $29.29 | 2 | $0 (2018) |
| Millennium Pharmaceuticals, Inc. | $28.36 | 2 | $0 (2017) |
| EISAI INC. | $25.18 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.88 | 1 | Daiichi Sankyo Inc. ($49.88) |
| 2023 | $107.28 | 1 | Seagen Inc. ($107.28) |
| 2020 | $35.35 | 2 | AstraZeneca Pharmaceuticals LP ($20.07) |
| 2019 | $74.32 | 5 | E.R. Squibb & Sons, L.L.C. ($16.67) |
| 2018 | $275.38 | 11 | TerSera Therapeutics LLC ($102.28) |
| 2017 | $93.38 | 6 | Novartis Pharmaceuticals Corporation ($36.85) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $49.88 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $107.28 | General |
| Category: Oncology | ||||||
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.07 | General |
| 01/23/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $15.28 | General |
| 07/30/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Oncology | ||||||
| 07/09/2019 | Roche Diagnostics Corporation | TD BenchMark IHC/ISH and Special Stains Reagents (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Tissue Diagnostics | ||||||
| 07/01/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| 03/25/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Oncology | ||||||
| 02/13/2019 | EISAI INC. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Oncology | ||||||
| 12/06/2018 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $12.71 | General |
| 09/29/2018 | TerSera Therapeutics LLC | ZOLADEX (Drug) | Food and Beverage | In-kind items and services | $90.39 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2018 | TerSera Therapeutics LLC | ZOLADEX (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $18.29 | General |
| 08/23/2018 | Roche Diagnostics Corporation | TD BenchMark Platforms (Device) | Food and Beverage | In-kind items and services | $54.34 | General |
| Category: Tissue Diagnostics | ||||||
| 07/16/2018 | Amgen Inc. | Neulasta (Biological), NEUPOGEN, Vectibix | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 06/25/2018 | Eisai Inc. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $10.79 | General |
| Category: Oncology | ||||||
| 05/03/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: BioOncology | ||||||
| 04/30/2018 | Roche Diagnostics Corporation | TD BenchMark Platforms (Device) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Tissue Diagnostics | ||||||
| 02/05/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Oncology | ||||||
| 01/18/2018 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 12/05/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2017 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $16.58 | General |
| 07/17/2017 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2017 | Millennium Pharmaceuticals, Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 03/20/2017 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,563 | 2,481 | $368,488 | $72,882 |
| 2022 | 19 | 1,632 | 2,363 | $313,748 | $68,502 |
| 2021 | 21 | 1,880 | 2,724 | $319,735 | $76,320 |
| 2020 | 20 | 1,627 | 2,373 | $302,362 | $74,578 |
Total Patients
6,702
Total Services
9,941
Medicare Billing
$292,282
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 358 | 638 | $79,750 | $18,201 | 22.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 90 | 139 | $38,086 | $8,757 | 23.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 96 | 362 | $32,580 | $8,046 | 24.7% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 33 | 33 | $20,691 | $4,574 | 22.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 113 | 135 | $28,620 | $3,678 | 12.9% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2023 | 37 | 110 | $12,100 | $3,318 | 27.4% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2023 | 36 | 53 | $14,098 | $2,864 | 20.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 103 | 136 | $23,936 | $2,821 | 11.8% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 109 | 123 | $22,632 | $2,641 | 11.7% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 22 | 23 | $10,258 | $2,625 | 25.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 69 | 80 | $10,207 | $2,317 | 22.7% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Office | 2023 | 13 | 50 | $12,100 | $1,726 | 14.3% |
| 84165 | Protein measurement, serum | Facility | 2023 | 117 | 122 | $7,564 | $1,710 | 22.6% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Facility | 2023 | 12 | 36 | $9,196 | $1,243 | 13.5% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 17 | 22 | $4,576 | $1,076 | 23.5% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 16 | 19 | $5,054 | $1,048 | 20.7% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2023 | 68 | 73 | $5,037 | $1,031 | 20.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 14 | 41 | $3,690 | $913.81 | 24.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 14 | 21 | $4,872 | $690.54 | 14.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 23 | 25 | $5,300 | $686.25 | 12.9% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 33 | 33 | $6,072 | $634.54 | 10.5% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 48 | 60 | $2,460 | $587.33 | 23.9% |
| 88141 | Pap test | Office | 2023 | 32 | 32 | $3,168 | $554.10 | 17.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 51 | 60 | $2,280 | $522.99 | 22.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 13 | 29 | $2,465 | $275.98 | 11.2% |
About Dr. Aimee Popp, MD
Dr. Aimee Popp, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336270875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aimee Popp, MD has received a total of $635.59 in payments from pharmaceutical and medical device companies, with $49.88 received in 2024. These payments were reported across 26 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($635.59).
As a Medicare-enrolled provider, Popp has provided services to 6,702 Medicare beneficiaries, totaling 9,941 services with total Medicare billing of $292,282. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Marietta, GA
- Active Since 03/08/2007
- Last Updated 11/01/2019
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1336270875
Products in Payments
- TUKYSA (Drug) $107.28
- ZOLADEX (Drug) $102.28
- TD BenchMark Platforms (Device) $66.83
- NINLARO (Drug) $57.82
- Enhertu (Drug) $49.88
- MEKINIST (Drug) $36.85
- Halaven (Drug) $25.18
- Herceptin (Biological) $16.68
- Xermelo (Drug) $16.24
- Neulasta (Biological) $16.02
- LYNPARZA (Drug) $15.35
- TD BenchMark IHC/ISH and Special Stains Reagents (Device) $13.99
- FOUNDATIONONE (Device) $11.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Marietta
Sara Acree, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $10,231
Anatomic Pathology & Clinical Pathology $10,231
Dr. Judy Sequeira, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $1,178
Anatomic Pathology & Clinical Pathology $1,178
Dr. Matthew Macatol, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $907.58
Anatomic Pathology & Clinical Pathology $907.58
Burton Kim, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $771.04
Anatomic Pathology & Clinical Pathology $771.04
Haohai Liang, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $380.57
Anatomic Pathology & Clinical Pathology $380.57
Dr. Sara Nash, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $217.90
Anatomic Pathology & Clinical Pathology $217.90